Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation

Trends in Endocrinology and Metabolism

Volumn 21, Issue 3, 2010, Pages 166-173

  Liu, Yan Yun ^a   Brent, Gregory A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A OXIDASE; CARNITINE PALMITOYLTRANSFERASE I; CARNITINE PALMITOYLTRANSFERASE I ALPHA; CELL NUCLEUS RECEPTOR; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CYCLIC AMP; FATTY ACID; G PROTEIN COUPLED RECEPTOR; HETERODIMER; LIVER X RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; THYROID HORMONE; UNCLASSIFIED DRUG;

BILE ACID SYNTHESIS; BINDING SITE; CATALYSIS; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DIABETES MELLITUS; DNA BINDING; DYSLIPIDEMIA; FATTY ACID OXIDATION; FATTY LIVER; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; HORMONE ACTION; HUMAN; LIPOGENESIS; METABOLIC REGULATION; MOLECULAR INTERACTION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; METABOLIC DISEASES; MODELS, BIOLOGICAL; RECEPTORS, THYROID HORMONE; SIGNAL TRANSDUCTION; THYROID HORMONES; TRANSCRIPTION FACTORS;

EID: 77949329263     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2009.11.004     Document Type: Review

References (73)

1. Oetting A., Yen P.M. New insights into thyroid hormone action. Best Pract. Res. Clin. Endocrinol. Metab. 2007, 21:193-208.
2. Klein I., Danzi S. Thyroid disease and the heart. Circulation 2007, 116:1725-1735.
3. Hollenberg A.N. The role of the thyrotropin-releasing hormone (TRH) neuron as a metabolic sensor. Thyroid 2008, 18:131-139.
4. Fox C.S., et al. Relation of thyroid function to body weight. Arch. Intern. Med. 2008, 168:587-592.
5. Brenta G., et al. Potential therapeutic applications of thyroid hormone analogs. Nat. Clin. Pract. Endocrinol. Metab. 2007, 3:632-640.
6. Baxter J.D., Webb P. Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat. Rev. Drug Discov. 2009, 8:308-320.
7. Araki O., et al. Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms. Mol. Endocrinol. 2009, 23:308-315.
8. Gereben B., et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr. Rev. 2008, 29:898-938.
9. Watanabe M., et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006, 439:484-489.
10. Kim B. Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid 2008, 18:141-144.
11. Silva J.E., Bianco S.D. Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid 2008, 18:157-165.
12. Crunkhorn S., Patti M.E. Links between thyroid hormone action, oxidative metabolism, and diabetes risk?. Thyroid 2008, 18:227-237.
13. Liu Y.Y., et al. A thyroid hormone receptor α gene mutation (P398H) is associated with visceral adiposity and impaired catecholamine-stimulated lipolysis in mice. J. Biol. Chem. 2003, 278:38913-38920.
14. Ribeiro M.O., et al. Thyroid hormone-sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific. J. Clin. Invest. 2001, 108:97-105.
15. Ribeiro, M.O. et al. Expression of uncoupling protein 1 in mouse brown adipose tissue is thyroid hormone receptor β isoform-specific and required for adaptive thermogenesis. Endocrinology (epublished ahead of publication November 11, 2009).
16. Chiamolera M.I., Wondisford F.E. Minireview: thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology 2009, 150:1091-1096.
17. Potenza M., et al. Excess thyroid hormone and carbohydrate metabolism. Endocr. Pract. 2009, 15:254-262.
18. Sugden M.C., Holness M.J. Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance. Biochem. Soc. Trans. 2008, 36:891-900.
19. Holness M.J., et al. PPARα activation and increased dietary lipid oppose thyroid hormone signaling and rescue impaired glucose-stimulated insulin secretion in hyperthyroidism. Am. J. Physiol. Endocrinol. Metab. 2008, 295:1380-1389.
20. Hashimoto K., et al. Carbohydrate response element binding protein gene expression is positively regulated by thyroid hormone. Endocrinology 2009, 150:3417-3424.
21. Oppenheimer J.H., et al. Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, an thermogenesis in rat. J. Clin. Invest. 1991, 87:125-132.
22. Ying H., et al. Impaired adipogenesis caused by a mutated thyroid hormone α1 receptor. Mol. Cell. Biol. 2007, 27:2359-2371.
23. Gullberg H., et al. Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7 α-hydroxylase (CYP7A) response to thyroid hormone but displays enhanced resistance to dietary cholesterol. Mol. Endocrinol. 2000, 14:1739-1749.
24. Erion M.D., et al. Targeting thyroid hormone receptor-β agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:15490-15495.
25. Shulman A.I., Mangelsdorf D.J. Retinoid X receptor heterodimers in the metabolic syndrome. N. Engl. J. Med. 2005, 353:604-615.
26. Li Q., et al. Fatty acyl-CoAs are potent inhibitors of the nuclear thyroid hormone receptor in vitro. J. Biochem. 1990, 107:699-702.
27. Juge-Aubry C.E., et al. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat. J. Biol. Chem. 1995, 270:18117-18122.
28. Shin D.J., Osborne T.F. Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding protein-2 (SREBP-2). J. Biol. Chem. 2003, 278:34114-34118.
29. Hashimoto K., et al. Mouse sterol response element binding protein-1c gene expression is negatively regulated by thyroid hormone. Endocrinology 2006, 147:4292-4302.
30. Bengoechea-Alonso M.T., Ericsson J. SREBP in signal transduction: cholesterol metabolism and beyond. Curr. Opin. Cell. Biol. 2007, 19:215-222.
31. Zhang Y., et al. SREBP-1 integrates the actions of thyroid hormone, insulin, cAMP, and medium-chain fatty acids on ACCα transcription in hepatocytes. J. Lipid Res. 2003, 44:356-368.
32. Lopez D., et al. Activation of the hepatic LDL receptor promoter by thyroid hormone. Biochim. Biophys. Acta 2007, 1771:1216-1225.
33. Goldstein J.L., et al. Protein sensors for membrane sterols. Cell 2006, 124:35-46.
34. Konig B., et al. Activation of PPARα lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2. Biochem. Pharmacol. 2007, 73:574-585.
35. Tamehiro N., et al. Sterol regulatory element-binding protein-2- and liver X receptor-driven dual promoter regulation of hepatic ABC transporter A1 gene expression: mechanism underlying the unique response to cellular cholesterol status. J. Biol. Chem. 2007, 282:21090-21099.
36. Huuskonen J., et al. Regulation of ATP-binding cassette transporter A1 transcription by thyroid hormone receptor. Biochemistry 2004, 43:1626-1632.
37. Tancevski I., et al. Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5′-triphosphate-binding cassette transporter 1 expression. Endocrinology 2008, 149:3708-3712.
38. Wong J., et al. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. Biochem. J. 2006, 400:485-491.
39. Chiang J.Y. Bile acids: regulation of synthesis. J. Lipid Res. 2009, 50:1955-1966.
40. Cheema S.K., Agellon L.B. The murine and human cholesterol 7alpha-hydroxylase gene promoters are differentially responsive to regulation by fatty acids mediated via peroxisome proliferator-activated receptor alpha. J. Biol. Chem. 2000, 275:12530-12536.
41. Hashimoto K., et al. Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. J. Biol. Chem. 2006, 281:295-302.
42. Kawai K., et al. Unliganded thyroid hormone receptor-beta1 represses liver X receptor alpha/oxysterol-dependent transactivation. Endocrinology 2004, 145:5515-5524.
43. Drover V.A., et al. A distinct thyroid hormone response element mediates repression of the human cholesterol 7alpha-hydroxylase (CYP7A1) gene promoter. Mol. Endocrinol. 2002, 16:14-23.
44. Ellis E.C. Suppression of bile acid synthesis by thyroid hormone in primary human hepatocytes. World J. Gastroenterol. 2006, 12:4640-4645.
45. Agellon L.B., et al. Dietary cholesterol fails to stimulate the human cholesterol 7alpha-hydroxylase gene (CYP7A1) in transgenic mice. J. Biol. Chem. 2002, 277:20131-20134.
46. Patel D.D., et al. The effect of peroxisome-proliferator-activated receptor-alpha on the activity of the cholesterol 7 alpha-hydroxylase gene. Biochem. J. 2000, 351:747-753.
47. Duffy D., Rader D.J. Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport. Circulation 2006, 113:1140-1150.
48. Minnich A., et al. A potent PPARα agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2001, 280:E270-E279.
49. Jackson-Hayes L., et al. A thyroid hormone response unit formed between the promoter and first intron of the carnitine palmitoyltransferase-Iα gene mediates the liver-specific induction by thyroid hormone. J. Biol. Chem. 2003, 278:7964-7972.
50. Louet J.F., et al. Regulation of liver carnitine palmitoyltransferase I gene expression by hormones and fatty acids. Biochem. Soc. Trans. 2001, 29:310-316.
51. Napal L., et al. An intronic peroxisome proliferator-activated receptor-binding sequence mediates fatty acid induction of the human carnitine palmitoyltransferase 1A. J. Mol. Biol. 2005, 354:751-759.
52. Zhang Y., et al. Peroxisomal proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha) enhances the thyroid hormone induction of carnitine palmitoyltransferase I (CPT-I alpha). J. Biol. Chem. 2004, 279:53963-53971.
53. Liu Y.Y., et al. A mutant thyroid hormone receptor alpha antagonizes peroxisome proliferator-activated receptor alpha signaling in vivo and impairs fatty acid oxidation. Endocrinology 2007, 148:1206-1217.
54. Sjogren M., et al. Hypermetabolism in mice caused by the central action of an unliganded thyroid hormone receptor alpha1. EMBO J. 2007, 26:4535-4545.
55. Zhang Y., et al. Thyroid hormone stimulates acetyl-coA carboxylase-alpha transcription in hepatocytes by modulating the composition of nuclear receptor complexes bound to a thyroid hormone response element. J. Biol. Chem. 2001, 276:974-983.
56. Chu R., et al. Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:11593-11597.
57. Araki O., et al. Thyroid hormone receptor beta mutants: dominant negative regulators of peroxisome proliferator-activated receptor gamma action. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:16251-16256.
58. Huang C., Freake H.C. Thyroid hormone regulates the acetyl-CoA carboxylase PI promoter. Biochem. Biophys. Res. Commun. 1998, 249:704-708.
59. Yin L., et al. Sterol regulatory element-binding protein-1 interacts with the nuclear thyroid hormone receptor to enhance acetyl-CoA carboxylase-alpha transcription in hepatocytes. J. Biol. Chem. 2002, 277:19554-19565.
60. Knight B.L., et al. A role for PPARα in the control of SREBP activity and lipid synthesis in the liver. Biochem. J. 2005, 389:413-421.
61. Talukdar S., et al. Chenodeoxycholic acid suppresses the activation of acetyl-coenzyme A carboxylase-alpha gene transcription by the liver X receptor agonist T0-901317. J. Lipid Res. 2007, 48:2647-2663.
62. Cha J.Y., Repa J.J. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J. Biol. Chem. 2007, 282:743-751.
63. LaFave L.T., et al. Minireview: S14: insights from knockout mice. Endocrinology 2006, 147:4044-4047.
64. tm1cnm) and diet-induced obesity. Mol. Cell. Endocrinol. 2009, 302:99-107.
65. Roduit R., et al. A role for the malonyl-CoA/long-chain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli. Diabetes 2004, 53:1007-1019.
66. Mitro N., et al. The nuclear receptor LXR is a glucose sensor. Nature 2007, 445:219-223.
67. Lazar M.A., Wilson T.M. Sweet dreams for LXR. Cell Metab. 2007, 5:159-161.
68. Skarulis, M.C. et al. Thyroid hormone induced brown adipose tissue and amelioration of diabetes in a patient with extreme insulin resistance. J. Clin. Endocrinol. Metab. (epublished ahead of publication November 6, 2009).
69. Arrese M. Burning hepatic fat: therapeutic potential for liver-specific thyromimetics in the treatment of nonalcoholic fatty liver disease. Hepatology 2009, 49:348-352.
70. Pihlajamaki J., et al. Thyroid hormone-related regulation of gene expression in human fatty liver. J. Clin. Endocrinol. Metab. 2009, 94:3521-3529.
71. Perra A., et al. Thyroid hormone (T3) and TRβ agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats. FASEB J. 2008, 22:2981-2989.
72. Cable E.E., et al. Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. Hepatology 2009, 49:407-417.
73. Grundy S.M. Thyroid mimetic as an option for lowering low-density lipoprotein. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:409-410.